Chrysanthos Stergiopoulos

Dr. Chrysanthos Stergiopoulos

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
Chrysanthos StergiopoulosChrysanthos Stergiopoulos
Chrysanthos Stergiopoulos
FTFotios Tsopelas
Fotios Tsopelas
KVKlara Valko
Klara Valko
The major causes of failure of drug discovery compounds in clinics are the lack of efficacy and toxicity. To reduce late-stage failures in the drug discovery process, it is essential to estimate early the probability of adverse effects and potential toxicity. Cardiotoxicity is one of the most often observed problems related to a compound's inhibition of the hERG channel responsible for the potassium cation flux. Biomimetic HPLC methods can be used for the early screening of a compound's lipophilicity, protein binding and phospholipid partition. Based on the published hERG pIC50 data of 90 marketed drugs and their measured biomimetic properties, a model has been developed to predict the hERG inhibition using the measured binding of compounds to alpha-1-acid-glycoprotein (AGP) and immobilised artificial membrane (IAM). A representative test set of 16 compounds was carefully selected. The training set, involving the remaining compounds, served to establish the linear model. The mechanistic model supports the hypothesis that compounds have to traverse the cell membrane and bind to the hERG ion channel to cause the inhibition. The AGP and the hERG ion channel show structural similarity, as both bind positively charged compounds with strong shape selectivity. In contrast, a good IAM partition is a prerequisite for cell membrane traversal. For reasons of comparison, a corresponding model was derived by replacing the measured biomimetic properties with calculated physicochemical properties. The model established with the measured biomimetic binding properties proved to be superior and can explain over 70% of the variance of the hERG pIC50 values. ©2021 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

7 November 2018 in Metals
Verified
Journal Article
Open access
PDF file
Maria Ochsenkühn-PetropoulouMaria Ochsenkühn-Petropoulou
Maria Ochsenkühn-Petropoulou
LTLamprini Areti Tsakanika
Lamprini Areti Tsakanika
TLTheopisti Lymperopoulou
Theopisti Lymperopoulou
KOKlaus-Michael Ochsenkuehn
Klaus-Michael Ochsenkuehn
KHKonstantinos Hatzilyberis
Konstantinos Hatzilyberis
FTFotios Tsopelas
Fotios Tsopelas
Bauxite residue (BR) is a well promising resource for critical metals, especially scandium (Sc), a rare and expensive metal with increasing applications in advanced technology. Greek BR seems to significantly favor a commercially viable recovery of Sc combining optimized leaching and advanced separation techniques. Leaching with mineral acids emerges as the dominant selection compared to other techniques. This study investigates an optimized leaching condition set for Sc recovery, using the most advantageous option of sulfuric acid. The main target is to develop a leaching scale-up process to be established in the premises of Mytilineos S.A. (formerly Aluminium of Greece, the largest Greek alumina and aluminum producer), taking into account the feed requirements of a subsequent advanced ion exchanged procedure. Several parameters were studied individually or combined in order to achieve high Sc concentration in the leachate and to ensure selectivity, especially concerning iron. The most significant parameters prove to be the solid-to-liquid ratio (S/L), the final pH value, and the leachate’s recycling. The proposed process, with low molarities of sulfuric acid and ambient conditions, integrates rapidly, leading to high and selective Sc recovery. Finally, a leaching process flow diagram under continuous operation on an industrial scale is developed.

1 May 2017 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
FTFotios Tsopelas
Fotios Tsopelas
Chrysanthos StergiopoulosChrysanthos Stergiopoulos
Chrysanthos Stergiopoulos
LTLamprini-Areti Tsakanika
Lamprini-Areti Tsakanika
MOMaria Ochsenkühn-Petropoulou
Maria Ochsenkühn-Petropoulou
ATAnna Tsantili-Kakoulidou
Anna Tsantili-Kakoulidou

1 June 2019 in Chemosphere
Verified
Journal Article
Closed access
Chrysanthos StergiopoulosChrysanthos Stergiopoulos
Chrysanthos Stergiopoulos
DMDimitra Makarouni
Dimitra Makarouni
ATAnna Tsantili-Kakoulidou
Anna Tsantili-Kakoulidou
MOMaria Ochsenkühn-Petropoulou
Maria Ochsenkühn-Petropoulou
FTFotios Tsopelas
Fotios Tsopelas

22 September 2018 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
FTFotios Tsopelas
Fotios Tsopelas
Chrysanthos StergiopoulosChrysanthos Stergiopoulos
Chrysanthos Stergiopoulos
ATAnna Tsantili-Kakoulidou
Anna Tsantili-Kakoulidou
Immobilized Artificial Membrane (IAM) chromatography constitutes a valuable tool for medicinal chemists to prioritize drug candidates in early drug development. The retention on IAM stationary phases encodes lipophilicity, electrostatic and other secondary interactions contrary to traditional octanol-water partitioning. An increasing number of publications in recent years have suggested that IAM indices, including isocratic log k(IAM) or extrapolated log kw(IAM) retention factors, chromatographic hydrophobicity index CHI(IAM) or the polarity parameter Δlog kw(IAM) can successfully model the passage of xeniobiotics through biological membranes and barriers and predict pharmacokinetic properties, often in combination with additional descriptors. Examples referring to the modeling of human oral absorption, blood-brain penetration and skin partition are described. More recently, IAM chromatography has been applied to estimate toxicological endpoints in regard to drug safety, such as phospholipidosis potential, or in regard to chemical risk hazards including the bioconcentration factor and aquatic organisms’ toxicity. The promising results in both medicinal chemistry and in environmental science in combination with the speed, reproducibility and low analyte consumption suggest that a broader application of IAM chromatography in the early drug discovery process and in ecotoxicity may save time and money in initial drug candidate selection and will contribute to a reduced risk hazard of chemicals.

6 December 2024 in Molecules
Verified
Journal Article
Open access
PDF file
KLKonstantina Theodora Laina
Konstantina Theodora Laina
CDChristina G. Drosou
Christina G. Drosou
Chrysanthos StergiopoulosChrysanthos Stergiopoulos
Chrysanthos Stergiopoulos
PEPanagiota Eleni
Panagiota Eleni
Magdalini KrokidaMagdalini Krokida
Magdalini Krokida
This study presents the synergistic application of ultrasound- and microwave-assisted extraction (UAE–MAE) as a novel and efficient method for recovering bioactive compounds from the medicinal plants oregano, rosemary, Hypericum perforatum, and chamomile. Extraction parameters, including microwave (MW) power, ultrasound (US) power, and extraction time, were optimized using the response surface methodology (RSM), with ethanol as the solvent. Extracts were evaluated for total phenolic content (TPC) via the Folin–Ciocalteu method and antioxidant activity (IC50) using the DPPH assay. High-performance liquid chromatography with diode array detection (HPLC–DAD) identified the main bioactive compounds contributing to their antioxidant and therapeutic potential. The optimized UAE–MAE conditions enhanced phenolic recovery and antioxidant potential across all plants. Notably, Hypericum perforatum exhibited the highest TPC (53.7 mg GAE/g) and strongest antioxidant activity (IC50 29.8 mg extract/g) under 200 W MW, 450 W US, and 12 min, yielding 14.5%. Rosemary achieved the highest yield (23.36%) with a TPC of 26.35 mg GAE/g and an IC50 of 40.75 mg extract/g at 200 W MW, 700 W US, and 8 min. Oregano’s optimal conditions (500 W MW, 700 W US, 12 min) produced a TPC of 34.99 mg GAE/g and an IC50 of 50.31 mg extract/g. Chamomile extracts demonstrated lower phenolic content and antioxidant activity but achieved significant yields under 500 W MW, 700 W US, and 5 min. This study highlights UAE–MAE’s superior efficiency, showcasing its potential to maximize phenolic recovery sustainably, making it a promising technique for industrial and therapeutic applications.